Sign in
CompletedNo phase

Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia

Key facts

Who runs it
Hospital Universitario Infanta Cristina
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
152 people enrolled
Started
1 Jan 2020
Ended
31 Dec 2024
Type of study
Observational, 2 groups
Treatments tested
  • Ferric Carboxymaltose (FCM)
Record updated
2 May 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Age over 18 years; on the SWL
  • Hemoglobine <13g/dL
  • Referred for major elective surgery requiring hospital admission (e.g., oncologic resections such as mastectomy, colon resection, nephrectomy, hysterectomy), typically involving general anesthesia and moderate to high morbidity risk, capable of understanding and consenting to the study
  • Physically and mentally able to complete assessments

Who cannot take part

  • Patients with hypersensitivity to FC, or any of its excipients. • Patients with active bleeding

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The prevalence of preoperative anaemia in patients undergoing major surgery is approximately 30%, and is independently associated with higher mortality, a higher rate of postoperative complications, and a greater probability of receiving a transfusion. In a prehabilitation program, the evaluation and correction of anaemia in the preoperative period is essential, as it is a risk factor for transfusions and complications. The main objectives of this study were to analyse the need for blood transfusion, post-surgical complications, hospital length of stay, ICU length of stay, hospital readmissions, and surgical wound infection in patients treated with ferric carboxymaltose (FC) before surgery. A total of 152 patients were included, of whom 96 received FC before the intervention and 56 received no treatment (control group).

The 2 groups in the trial

  • Control (Not surgical prehabilitation)

    This group received the standard preoperative patient assessment without going through a prehabilitation unit or undergoing any type of intervention. They did not receive this intervention because the surgical prehabilitation consultation had not yet been implemented at the hospital.

  • Interventional group (Surgical prehabilitation)

    This group received standardized care and assessments in a surgical prehabilitation consultation, including preoperative blood tests, correction of conditions such as anemia (including intravenous iron), and the necessary supplementation to optimize the patients.

    Treatment: Ferric Carboxymaltose (FCM)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of the Role of Preoperative Intravenous Iron in Patients Undergoing Surgery
Record updated
2 May 2025